Li et al. [36] also carried out an study to determine the usefulness of the exosomal GAS5 lncRNA (Exo-GAS5) as a biomarker for early stage non-small cell lung cancer (NSCLC) diagnosis. Here, GAS5 is linked to non-small cell lung carcinoma.